FDA to Begin Publishing Clinical Study Reports & Possibly Select CRLs

October 9, 2018

As seen in CenterWatch.com - Posted Oct. 9, 2018 - Original Article

Jan. 22, 2018 | A new FDA pilot program will publish information from sponsor-produced clinical study reports (CSR) — starting with documents volunteered by companies following a drug’s approval — as part of broader agency efforts to boost transparency in clinical trials and streamline the review process.


Making CSRs publicly available will provide more clarity on the FDA’s decisionmaking process, as well as offer detail into the clinical evidence submitted in successful NDAs, ...

Continued on CenterWatch

Previous Article
Transparency on trial: How to navigate FDAAA 801 final rule implementation and compliance
Transparency on trial: How to navigate FDAAA 801 final rule implementation and compliance

Next Article
As ClinicalTrials.gov Turns 10, Will We See Compliance Improve?
As ClinicalTrials.gov Turns 10, Will We See Compliance Improve?